Patents/Assignees

Kymera Therapeutics, Inc.

33 patents in portfolio

US12606568utility2026
SMARCA Degraders and Uses Thereof
0 cites
US12569485utility2026
SMARCA Inhibitors and Uses Thereof
0 cites
US12558427utility2026
IRAK Degraders and Uses Thereof
0 cites
US12551564utility2026
IRAK Degraders and Uses Thereof
0 cites
US12545659utility2026
IRAK Degraders and Uses Thereof
0 cites
US12540127utility2026
CRBN Ligands and Uses Thereof
0 cites
US12539295utility2026
IRAK Degraders and Uses Thereof
0 cites
US12528785utility2026
MDM2 Degraders and Uses Thereof
0 cites
US12497402utility2025
IRAK4 Degraders and Uses Thereof
0 cites
US12454520utility2025
Protein Degraders and Uses Thereof
0 cites
US12258341utility2025
IRAK Degraders and Uses Thereof
0 cites
US12187744utility2025
IRAK4 Degraders and Synthesis Thereof
0 cites
US12171768utility2024
IRAK4 Degraders and Uses Thereof
0 cites
US12168057utility2024
IRAK Degraders and Uses Thereof
0 cites
US12150995utility2024
IRAK Degraders and Uses Thereof
0 cites
US12097261utility2024
CDK2 Degraders and Uses Thereof
0 cites
US12091411utility2024
IRAK Degraders and Uses Thereof
0 cites
US12077555utility2024
STAT Degraders and Uses Thereof
0 cites
US12006329utility2024
Protein Degraders and Uses Thereof
0 cites
US11932635utility2024
CRBN Ligands and Uses Thereof
0 cites

Page 1 of 2Next →